2.33MMarket Cap-154P/E (TTM)
0.3990High0.3666Low22.43KVolume0.3989Open0.3851Pre Close8.44KTurnover0.64%Turnover RatioLossP/E (Static)6.01MShares6.000052wk High0.17P/B1.36MFloat Cap0.260052wk Low--Dividend TTM3.51MShs Float405.9000Historical High--Div YieldTTM8.41%Amplitude0.2600Historical Low0.3760Avg Price1Lot Size
Galmed Pharmaceuticals Stock Forum
Hope to see a continuation of Friday?
News
Benzinga· 1 min ago
News
i m bought n dead 🤣
WAR UPDATE!! Grrrrrr
Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
TEL AVIV, Israel, November 20, 2023 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical company for liver, metabolic and fibrotic diseases, announced today a delay of at least 6 months in the initiation of its Primary Sclerosing Cholangitis (PSC) Ph 2a Study.
In May ...
No comment yet